Abstract
The specific binding of γ-aminobutyric acid (GABA) to synaptic membranes prepared from the brains of rats with acute liver failure due to portacaval shunt and hepatic artery ligation was measured. No changes in the affinity or the density of the low- and high-affinity binding sites of the GABA receptor were observed, indicating that this model of acute hepatic encephalopathy is apparently not associated with altered GABAergic neurotransmission.
Similar content being viewed by others
References
Baraldi, M., and Zeneroli, M. L. (1982). Experimental hepatic encephalopathy: Changes in the binding of γ-aminobutyric acid.Science 216: 427–429.
Baraldi, M., Zeneroli, M. L., Ventura, E.,et al. (1984). Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: Reversal by a benzodiazepine antagonist.Clin. Sci. 67: 167–175.
Bassett, M. L., Mullen, K. D., Skolnick, P., and Jones, E. A. (1985). GABA and benzodiazepine receptor antagonists ameliorate hepatic encephalopathy in a rabbit model of fulminant hepatic failure.Hepatology 5: 1032.
Blitzer, B. L., Waggoner, J. G., Jones, E. A.,et al. (1978). A model of fulminant hepatic failure in the rabbit.Gastroenterology 74: 664–671.
Ferenci, P., Riederer, P., Jellinger, K., Schafer, D. F., and Jones, E. A. (1983). Changes in γ-aminobutyric acid receptors in patients with hepatic encephalopathy.Gastroenterology 84: 1371.
Ferenci, P., Zimmermann, Ch., and Ebner, J. (1986). Thioacetamide-induced acute liver failure in the rat -a suitable model for hepatic encephalopathy?J. Hepatol. 3 (Suppl. 1): 121.
Maddison, J. E., Dodd, P. R., Johnston, G. A. R., and Farrell, G. C. (1987). Brain GABA receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma GABA-like activity.Gastroenterology 93 (in press).
Munson, P. J., and Rodbard, D. (1980). LIGAND: A versatile computerized approach for characterization of ligand binding systems.Anal. Biochem. 107: 220–239.
Pappas, S. C. (1984). Increased y-aminobutyric acid (GABA) receptors in the brain precedes hepatic encephalopathy (HE) in fulminant hepatic failure (FHF).Hepatology 4: 1051.
Pappas, S. C., Levy, G. A., and Gordon, V. P. (1986). Decreased brain GABA binding in a model of fulminant hepatic failure (FHF): Evidence conflicting with the GABA hypothesis for hepatic encephalopathy (HE).Hepatology 6: 1106.
Rzepczynski, D., Zieve, L., Lindblad, S., and LaFontaine, D. (1986). In vivo studies of GABA-ergic effects in experimental hepatic encephalopathy.Hepatology 6: 902–905.
Schafer, D. F., and Jones, E. A. (1982). Hepatic encephalopathy and the γ-aminobutyric-acid neurotransmitter system.Lancet 1: 18–19.
Schafer, D. F., Fowler, J. M., Munson, P. J., Takur, A. K., Waggoner, J. G., and Jones, E. A. (1983). Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure.J. Lab. Clin. Med. 102: 870–880.
Schafer, D. F., Pappas, S. C., Brody, L. E., Jacobs, R., and Jones, E. A. (1984). Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug induced comas.Gastroenterology 86: 540–545.
Traber, P. G., Ganger, D. R., and Blei, A. T. (1986). Brain edema in rabbits with galactosamine-induced fulminant hepatitis. Regional differences and effects on intracranial pressure.Gastroenterology 91: 1347–1356.
Zieve, L., Ferenci, P., Rzepczynski, D., Ebner, J., and Zimmermann, Ch. (1987). A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural γ-aminobutyric acid (GABA) binding.Metab. Brain Dis. 2: 201–205.
Zukin, S. R., Young, A. B., and Snyder, S. H. (1974). Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system.Proc. Natl. Acad. Sci. 71: 4802–4807.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ferenci, P., Zieve, L., Ebner, J. et al. Postsynaptic γ-aminobutyric acid receptors in hepatic coma following portacaval shunt and hepatic artery ligation in the rat. Metabolic Brain Disease 2, 195–200 (1987). https://doi.org/10.1007/BF00999610
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00999610